dc.contributor.author | Biteker, Murat | |
dc.contributor.author | Başaran, Özcan | |
dc.contributor.author | Mert, Gurbet Ozge | |
dc.contributor.author | Doğan, Volkan | |
dc.contributor.author | Mert, Kadir Uğur | |
dc.date.accessioned | 2020-11-20T15:05:39Z | |
dc.date.available | 2020-11-20T15:05:39Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 0957-5235 | |
dc.identifier.issn | 1473-5733 | |
dc.identifier.uri | https://doi.org/10.1097/MBC.0000000000000246 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12809/3044 | |
dc.description | WOS: 000353828800024 | en_US |
dc.description | PubMed ID: 25923781 | en_US |
dc.item-language.iso | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics | en_US |
dc.item-type | letter | en_US |
dc.contributor.department | MÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Biteker, Murat | |
dc.identifier.doi | 10.1097/MBC.0000000000000246 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 477 | en_US |
dc.identifier.endpage | 478 | en_US |
dc.relation.journal | Blood Coagulation & Fibrinolysis | en_US |
dc.relation.publicationcategory | Diğer | en_US |